As of 2026-09-08, the Relative Valuation of EyePoint Pharmaceuticals Inc (EYPT) is (40.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.58 USD, the upside of EyePoint Pharmaceuticals Inc based on Relative Valuation is -981.1%.
The range of the Relative Valuation is (25.79) - (54.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 21.4x | 13.4x |
| Forward P/E multiples | 8.7x - 18.5x | 14.0x |
| Fair Price | (25.79) - (54.65) | (40.35) |
| Upside | -663.1% - -1293.2% | -981.1% |
| Date | P/E |
| 2026-09-04 | -1.55 |
| 2026-09-03 | -1.55 |
| 2026-09-02 | -1.62 |
| 2026-09-01 | -1.55 |
| 2026-08-31 | -1.52 |
| 2026-08-28 | -1.52 |
| 2026-08-27 | -1.57 |
| 2026-08-26 | -1.69 |
| 2026-08-25 | -1.70 |
| 2026-08-24 | -1.65 |
| 2026-08-21 | -1.80 |
| 2026-08-20 | -1.83 |
| 2026-08-19 | -2.13 |
| 2026-08-18 | -1.85 |
| 2026-08-17 | -1.65 |
| 2026-08-14 | -5.00 |
| 2026-08-13 | -4.57 |
| 2026-08-12 | -4.59 |
| 2026-08-11 | -4.42 |
| 2026-08-10 | -4.43 |
| 2026-08-07 | -4.71 |
| 2026-08-06 | -4.35 |
| 2026-08-05 | -4.15 |
| 2026-08-04 | -3.95 |
| 2026-08-03 | -4.21 |
| 2026-07-31 | -4.15 |
| 2026-07-30 | -4.36 |
| 2026-07-29 | -4.04 |
| 2026-07-28 | -4.05 |
| 2026-07-27 | -4.21 |
| 2026-07-24 | -4.13 |
| 2026-07-23 | -4.23 |
| 2026-07-22 | -4.29 |
| 2026-07-21 | -4.42 |
| 2026-07-20 | -4.29 |
| 2026-07-17 | -4.51 |
| 2026-07-16 | -4.42 |
| 2026-07-15 | -4.69 |
| 2026-07-14 | -4.65 |
| 2026-07-13 | -4.84 |
| 2026-07-10 | -4.99 |
| 2026-07-09 | -5.03 |
| 2026-07-08 | -4.75 |
| 2026-07-07 | -4.75 |
| 2026-07-06 | -4.89 |
| 2026-07-02 | -4.74 |
| 2026-07-01 | -4.47 |
| 2026-06-30 | -4.85 |
| 2026-06-29 | -4.78 |
| 2026-06-26 | -4.63 |